Physician profile
Joel W Everett
NPI 1710195607
$2,998.15
in general payments reported to CMS, 2019-2025
11 companies · $561 in 2025
The $561 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $481 · 2023: $769 · 2024: $1,066 · 2025: $561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,395.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $893.75 | 2021-2025 | Evenity, Krystexxa |
| Abbvie INC. | $497.00 | 2022-2024 | |
| Novo Nordisk INC | $365.69 | 2022-2024 | Wegovy |
| Janssen Pharmaceuticals, INC | $334.81 | 2022-2023 | Spravato |
| Ibsa Pharma INC. | $250.00 | 2024 | Tirosint |
| Exeltis, USA INC. | $125.00 | 2025 | |
| Pharming Healthcare, INC. | $124.99 | 2024 | Ruconest |
| Lilly USA, LLC | $109.31 | 2024 | Mounjaro |
| Alexion Pharmaceuticals, INC. | $102.72 | 2023 | Ultomiris |
| Alkermes, INC. | $100.00 | 2022 | |
| Xeris Pharmaceuticals, INC. | $94.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Everett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.